Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 15:17
  • Read more about Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

Enhanced genetic analysis of type 1 diabetes by selecting variants on both effect size and significance, and by integration with autoimmune thyroid disease

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 14:52
  • Read more about Enhanced genetic analysis of type 1 diabetes by selecting variants on both effect size and significance, and by integration with autoimmune thyroid disease

A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 14:44
  • Read more about A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19

Atlas of epistasis

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 14:38
  • Read more about Atlas of epistasis

Genetic analyses implicate complex links between adult testosterone levels and health and disease.

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 14:35
  • Read more about Genetic analyses implicate complex links between adult testosterone levels and health and disease.

Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 14:21
  • Read more about Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder

Genetic variant in SPDL1 reveals novel mechanism linking pulmonary fibrosis risk and cancer protection

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 14:15
  • Read more about Genetic variant in SPDL1 reveals novel mechanism linking pulmonary fibrosis risk and cancer protection

GWAS meta-analyses clarify the genetics of cervical phenotypes and inform risk stratification for cervical cancer

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 14:07
  • Read more about GWAS meta-analyses clarify the genetics of cervical phenotypes and inform risk stratification for cervical cancer

Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 13:16
  • Read more about Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction

Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation

Submitted by Frida Mäkelä on Mon, 10/17/2022 - 12:59
  • Read more about Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 422
  • Page 423
  • Page 424
  • Page 425
  • Current page 426
  • Page 427
  • Page 428
  • Page 429
  • Page 430
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement